DK2374468T3 - Anvendelse af peptid af APL-typen til behandling af inflammatoriske tarmsygdomme og type 1-diabetes - Google Patents
Anvendelse af peptid af APL-typen til behandling af inflammatoriske tarmsygdomme og type 1-diabetesInfo
- Publication number
- DK2374468T3 DK2374468T3 DK09804226.0T DK09804226T DK2374468T3 DK 2374468 T3 DK2374468 T3 DK 2374468T3 DK 09804226 T DK09804226 T DK 09804226T DK 2374468 T3 DK2374468 T3 DK 2374468T3
- Authority
- DK
- Denmark
- Prior art keywords
- type
- peptide
- apl
- diabetes
- inflammatory bowel
- Prior art date
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 3
- 208000022559 Inflammatory bowel disease Diseases 0.000 title 1
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 title 1
- 208000011231 Crohn disease Diseases 0.000 abstract 2
- 206010012601 diabetes mellitus Diseases 0.000 abstract 2
- 206010009900 Colitis ulcerative Diseases 0.000 abstract 1
- 102000002812 Heat-Shock Proteins Human genes 0.000 abstract 1
- 108010004889 Heat-Shock Proteins Proteins 0.000 abstract 1
- 210000001744 T-lymphocyte Anatomy 0.000 abstract 1
- 201000006704 Ulcerative Colitis Diseases 0.000 abstract 1
- 230000006907 apoptotic process Effects 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 210000001035 gastrointestinal tract Anatomy 0.000 abstract 1
- 230000006882 induction of apoptosis Effects 0.000 abstract 1
- 210000005206 intestinal lamina propria Anatomy 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 210000005087 mononuclear cell Anatomy 0.000 abstract 1
- 210000005259 peripheral blood Anatomy 0.000 abstract 1
- 239000011886 peripheral blood Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/03—Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Hematology (AREA)
- Marine Sciences & Fisheries (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CU20080254A CU23701A1 (es) | 2008-12-29 | 2008-12-29 | Método de tratamiento de enfermedades inflamatorias intestinales y diabetes tipo i |
| PCT/CU2009/000009 WO2010075824A1 (es) | 2008-12-29 | 2009-12-29 | Uso de peptido tipo apl para el tratamiento de enfermedades inflamatorias intestinales y diabetes tipo i |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK2374468T3 true DK2374468T3 (da) | 2013-12-09 |
Family
ID=41820665
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK09804226.0T DK2374468T3 (da) | 2008-12-29 | 2009-12-29 | Anvendelse af peptid af APL-typen til behandling af inflammatoriske tarmsygdomme og type 1-diabetes |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US8410057B2 (da) |
| EP (1) | EP2374468B1 (da) |
| JP (1) | JP5646506B2 (da) |
| KR (1) | KR101620341B1 (da) |
| CN (1) | CN102307587B (da) |
| AU (1) | AU2009335405B2 (da) |
| BR (1) | BRPI0923832B1 (da) |
| CA (1) | CA2748493C (da) |
| CU (1) | CU23701A1 (da) |
| DK (1) | DK2374468T3 (da) |
| ES (1) | ES2438096T3 (da) |
| MX (1) | MX2011007033A (da) |
| RU (1) | RU2524630C2 (da) |
| WO (1) | WO2010075824A1 (da) |
| ZA (1) | ZA201105320B (da) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PE20181295A1 (es) | 2015-09-01 | 2018-08-07 | First Wave Bio Inc | Metodos y composiciones para tratar afecciones asociadas a una respuesta inflamatoria anomala |
| CU24508B1 (es) * | 2017-12-29 | 2021-04-07 | Centro De Ingenieria Genetica Y Biotecnologia Biocubafarma | Composición farmacéutica que comprende péptido tipo apl |
| US10980756B1 (en) | 2020-03-16 | 2021-04-20 | First Wave Bio, Inc. | Methods of treatment |
| CU20200026A7 (es) * | 2020-04-13 | 2021-11-04 | Ct Ingenieria Genetica Biotecnologia | Péptido para el tratamiento del síndrome de la tormenta de citocinas |
| CN115671253B (zh) * | 2021-07-30 | 2024-02-27 | 河北菲尼斯生物技术有限公司 | Se-dr亲和肽在制备治疗风湿疾病的药物中的用途 |
| KR20250040663A (ko) * | 2022-07-22 | 2025-03-24 | 센트로 데 인제니에리아 제네티카 와이 바이오테크놀로지아 | 아포지질단백질 ai 또는 트랜스티레틴 내 문제와 연관된 질병을 치료하기 위한 펩타이드 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8003A (en) * | 1851-03-25 | Improvement in scythe-tastenings | ||
| DK0820303T3 (da) * | 1994-12-21 | 2003-10-06 | Yeda Res & Dev | p277 peptidanaloger og farmaceutiske sammensætninger, der omfatter dem, til behandling eller diagnosticering af diabetes |
| US6180103B1 (en) * | 1994-12-21 | 2001-01-30 | Yeda Research And Development Co., Ltd. | Peptide p277 analogs, and pharmaceutical compositions comprising them for treatment or diagnosis of diabetes |
| US6110746A (en) * | 1995-06-30 | 2000-08-29 | Yeda Research And Development Co. Ltd. | Peptides derived from human heat shock protein 60 for treatment of diabetes, compositions, methods and kits |
| IL114407A0 (en) * | 1995-06-30 | 1995-10-31 | Yeda Res & Dev | Novel peptides and pharmaceutical compositions comprising them |
| JP2004501061A (ja) * | 1999-12-15 | 2004-01-15 | ペプトル・リミテツド | 熱ショックタンパク質６０のフラグメントおよびアンタゴニスト |
| WO2005048914A2 (en) * | 2003-11-24 | 2005-06-02 | Yeda Research & Development Co. Ltd. | Dna vaccines encoding hsp60 peptide fragments for treating autoimmune diseases |
| CU23504A1 (es) * | 2004-09-24 | 2010-04-13 | Ct Ingenieria Genetica Biotech | Péptidos y derivados tipo apl de la hsp60 y composiciones farmacéuticas |
-
2008
- 2008-12-29 CU CU20080254A patent/CU23701A1/es unknown
-
2009
- 2009-12-29 ES ES09804226.0T patent/ES2438096T3/es active Active
- 2009-12-29 MX MX2011007033A patent/MX2011007033A/es active IP Right Grant
- 2009-12-29 EP EP09804226.0A patent/EP2374468B1/en active Active
- 2009-12-29 CA CA2748493A patent/CA2748493C/en active Active
- 2009-12-29 BR BRPI0923832-8A patent/BRPI0923832B1/pt active Search and Examination
- 2009-12-29 DK DK09804226.0T patent/DK2374468T3/da active
- 2009-12-29 KR KR1020117017870A patent/KR101620341B1/ko active Active
- 2009-12-29 CN CN200980156252.0A patent/CN102307587B/zh active Active
- 2009-12-29 US US13/142,471 patent/US8410057B2/en active Active
- 2009-12-29 JP JP2011543973A patent/JP5646506B2/ja active Active
- 2009-12-29 AU AU2009335405A patent/AU2009335405B2/en not_active Ceased
- 2009-12-29 WO PCT/CU2009/000009 patent/WO2010075824A1/es not_active Ceased
- 2009-12-29 RU RU2011131872/15A patent/RU2524630C2/ru active
-
2011
- 2011-07-19 ZA ZA2011/05320A patent/ZA201105320B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| RU2524630C2 (ru) | 2014-07-27 |
| CA2748493C (en) | 2017-08-22 |
| CU23701A1 (es) | 2011-09-21 |
| US20120035106A1 (en) | 2012-02-09 |
| EP2374468B1 (en) | 2013-09-11 |
| US8410057B2 (en) | 2013-04-02 |
| JP5646506B2 (ja) | 2014-12-24 |
| CN102307587A (zh) | 2012-01-04 |
| JP2012514013A (ja) | 2012-06-21 |
| BRPI0923832A2 (pt) | 2015-07-21 |
| BRPI0923832B1 (pt) | 2019-09-24 |
| CN102307587B (zh) | 2014-04-30 |
| AU2009335405B2 (en) | 2013-07-18 |
| WO2010075824A1 (es) | 2010-07-08 |
| ES2438096T3 (es) | 2014-01-15 |
| RU2011131872A (ru) | 2013-02-10 |
| CA2748493A1 (en) | 2010-07-08 |
| AU2009335405A1 (en) | 2011-08-25 |
| ZA201105320B (en) | 2012-04-25 |
| KR101620341B1 (ko) | 2016-05-12 |
| MX2011007033A (es) | 2011-07-20 |
| EP2374468A1 (en) | 2011-10-12 |
| KR20110119677A (ko) | 2011-11-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA201100621A1 (ru) | Лечение диабета у пациентов, у которых наблюдается недостаточный гликемический контроль несмотря на лечение пероральным или непероральным противодиабетическим лекарственным средством | |
| DK2374468T3 (da) | Anvendelse af peptid af APL-typen til behandling af inflammatoriske tarmsygdomme og type 1-diabetes | |
| EA201170149A1 (ru) | Новые аналоги инсулина пролонгированной активности | |
| CY1117869T1 (el) | Φαρμακοτεχνικες μορφες για απο του στοματος απελευθερωση προσροφητικων στο εντερο | |
| EA200971130A1 (ru) | Агонисты гуанилатциклазы, пригодные для лечения желудочно-кишечных нарушений, воспаления, рака и других заболеваний | |
| EA201891510A1 (ru) | Вазопротективное и кардиопротективное противодиабетическое лечение | |
| UA94734C2 (ru) | ТЕРАПЕВТИЧЕСКОЕ АНТИТЕЛО, КОТОРОЕ СВЯЗЫВАЕТСЯ С b-АМИЛОИДНЫМ ПЕПТИДОМ | |
| MX2011007397A (es) | Inhibidores de dpp-iv para el tratamiento de la diabetes en pacientes pediatricos. | |
| EA201300522A1 (ru) | Фармацевтические комбинации для лечения метаболических нарушений | |
| MY157564A (en) | Combination pharmaceutical composition and methods of treating functional diseases or conditions of gastrointestinal tract | |
| WO2006063093A3 (en) | Methods for diagnosis and treatment of crohn's disease | |
| DK1915620T3 (da) | Diagnose, behandling og prævention af vaskulære sygdomme ved hjælp af IL-1alpha-autoantistoffer | |
| EA201792030A1 (ru) | Лечение пациентов с сахарным диабетом 2 типа | |
| EA201300421A1 (ru) | Комбинированная терапия для лечения инфекции hcv | |
| MX353649B (es) | Proteinas protozoarias variables de superficie (vsp) como vehiculos para la administracion de farmacos. | |
| CY1119308T1 (el) | Συνδυασμοι με ενα πεπτιδιο κυκλοποιημενου σκελετου | |
| EP1997503A3 (en) | Treatment of melanoma with alpha thymosin peptides | |
| DK2096120T3 (da) | Anvendelse af sekreterede proteinprodukter til at forebygge og behandle pankreatiske sygdomme og/eller obesitet og/eller metabolsk syndrom | |
| Safatle-Ribeiro et al. | Hemorrhagic gastritis at the excluded stomach after Roux-en-Y gastric bypass | |
| TH93866B (th) | องค์ประกอบที่มีกรดโดโคซาเพนทาอีโนอิค | |
| TH93866A (th) | องค์ประกอบที่มีกรดโดโคซาเพนทาอีโนอิค | |
| Chondronikola et al. | You have free access to this contentBariatric surgery and type 2 diabetes: are there weight loss-independent therapeutic effects of upper gastrointestinal bypass? | |
| Ananev et al. | Application of medical products on the basis of gelatin | |
| Aukerman | Do vitamin C supplements reduce cardiovascular disease mortality? | |
| PH12014500736A1 (en) | Formulation for prevention or treatment of diabetes |